Abstract
Basic fibroblast growth factor (bFGF) and human immunodeficiency virus type 1 (HIV-1) Tat protein synergize in inducing angiogenic Kaposi's sarcoma-like lesions in mice. Synergy is due to Tat, which enhances endothelial cell growth and type-IV collagenase expression in response to bFGF mimicking extracellular matrix proteins. The bFGF, extracellular Tat and Tat receptors are present in HIV-1-associated KS, which may explain the higher frequency and aggressiveness of this form compared to classical Kaposi's sarcoma where only bFGF is present.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
CDC Task Force on KS and opportunistic infections N. Engl. J. Med. 306, 248–252 (1982).
Safai, B. et al. Ann. Intern. Med. 103, 744–750 (1985).
Ruszczak, Z., Mayer-Da Silva, A. & Orfanos, C. E. Am. J. Dermatol. 9, 388–398 (1987).
Regezi, J. A. et al. Am. J. Pathol. 143, 240–249 (1993).
Ensoli, B., Barillari, G. & Gallo, R. C. Hematol. Oncol. Clin. North Am. 5, 281–295 (1991).
Folkman, J. & Klagsbrun, M. Science 235, 442–447 (1987).
Burgess, W. H. & Maciag, T. A. Rev. Biochem. 58, 575–606 (1989).
Nakamura, S. et al. Science 242, 426–430 (1988).
Salahuddin, S. Z. et al. Science 242, 430–433 (1988).
Ensoli, B. et al. Science 243, 223–226 (1989).
Ensoli, B. et al. J. clin. Invest. (in the press).
Xerri, L. et al. Am. J. Pathol. 138, 9–15 (1991).
Ensoli, B. et al. Nature 344, 84–86 (1990).
Ensoli, B. et al. J. Virol. 67, 277–287 (1993).
Barillari, G. et al. J. Immun. 149, 3727–3734 (1992).
Barillari, G., Gendelman, R., Gallo, R. C. & Ensoli, B. Proc. natn. Acad. Sci. U.S.A. 90, 7941–7945 (1993).
Albini, A., Barillari, G., Benelli, R., Gallo, R. C. & Ensoli, B. Proc. natn. Acad. Sci. U.S.A. (in the press).
Hober, D. et al. Clin. exp. Immun. 78, 329–333 (1989).
Fuchs, D. et al. J. Acquir. Immune Defic. Syndr. 5, 424–425 (1992).
Fan, J., Bass, H. Z. & Fahey, J. L. J. Immun. 151, 5031–5040 (1993).
Gay, C. G. & Winkles, J. A. Proc. natn. Acad. Sci. U.S.A. 88, 296–300 (1991).
Okamura, K. et al. J. biol. Chem. 266, 19162–19165 (1991).
Cordon-Cardo, C., Vlodavsky, I., Haimovitz-Friedman, A., Hicklin, D. & Fuks, Z. Lab. Invest. 63, 832–840 (1990).
Mahoney, S. E. et al. J. clin. Invest. 88, 174–185 (1991).
Fawell, S. et al. Proc. natn. Acad. Sci. U.S.A. 31, 664–668 (1994).
Hynes, R. O. Cell 69, 11–24 (1992).
Brooks, P. C., Clark, R. A. F. & Cheresh, D. A. Science 264, 569–571 (1994).
Buonaguro, L. et al. J. Virol. 66, 7159–7167 (1992).
Ingber, D. J. J. Cell Biochem. 47, 236–241 (1991).
Moscatelli, D. & Rifkin, D. B. Biochem. biophys. Acta 948, 67–85 (1988).
Liotta, L. A., Steeg, P. S. & Stetler-Stevenson, W. G. Cell 64, 327–336 (1991).
Mignatti, P., Tsuboi, R., Robbins, E. & Rifkin, D. J. Cell Biol. 108, 671–682 (1989).
Albini, A. et al. Int. J. Cancer 83, 775–779 (1991).
Seftor, R. E. B. et al. Proc. natn. Acad. Sci. U.S.A. 89, 1557–1561 (1992).
Seftor, R. E. B., Seftor, E., Stetler-Stevenson, W. G. & Hendrix, M. J. C. Cancer Res. 53, 3411–3415 (1993).
Werb, Z., Tkemisle, I., Behrendtsen, O., Crowley, E. & Damsky, C. H. J. Cell Biol. 109, 877–888 (1989).
Yang, J. et al. J. Immun. 152, 223–226 (1994).
Zhang, Y-M. et al. Am. J. Pathol. 144, 51–59 (1994).
Popovic, M., Sarngadharan, M. G., Read, E. & Gallo, R. C. Science 224, 497–500 (1984).
Gartner, S. et al. Science 233, 215–219 (1986).
Kubota, Y., Kleinman, H., Martin, G. R. & Lawley, T. J. J. Cell Biol. 107, 1589–1598 (1988).
Collier, I. et al. J. biol. Chem. 263, 6579–6587 (1988).
Vogel, J., Hinrich, S. H., Reynolds, R. K., Luciw, P. A. & Jay, G. Nature 335, 606–611 (1988).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ensoli, B., Gendelman, R., Markham, P. et al. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371, 674–680 (1994). https://doi.org/10.1038/371674a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/371674a0